Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1973 1
1978 1
1979 3
1980 3
1981 5
1982 12
1983 19
1984 24
1985 26
1986 27
1987 19
1988 33
1989 33
1990 29
1991 26
1992 32
1993 37
1994 26
1995 29
1996 48
1997 30
1998 44
1999 48
2000 50
2001 44
2002 59
2003 62
2004 52
2005 62
2006 94
2007 72
2008 51
2009 48
2010 29
2011 36
2012 49
2013 26
2014 36
2015 24
2016 38
2017 38
2018 37
2019 23
2020 22
2021 25
2022 22
2023 23
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

1,501 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder.
Grunze A, Amann BL, Grunze H. Grunze A, et al. Medicina (Kaunas). 2021 Apr 30;57(5):433. doi: 10.3390/medicina57050433. Medicina (Kaunas). 2021. PMID: 33946323 Free PMC article. Review.
Background and Objectives: This review is dedicated to the use of carbamazepine and its derivatives oxcarbazepine and eslicarbazepine in bipolar disorder and their relative strengths in treating and preventing new depressive or manic episodes. ...For eslicarbazepine …
Background and Objectives: This review is dedicated to the use of carbamazepine and its derivatives oxcarbazepine and eslicarbazepine …
Carbamazepine.
Alrashood ST. Alrashood ST. Profiles Drug Subst Excip Relat Methodol. 2016;41:133-321. doi: 10.1016/bs.podrm.2015.11.001. Epub 2015 Dec 31. Profiles Drug Subst Excip Relat Methodol. 2016. PMID: 26940169 Review.
This chapter includes the aspects of carbamazepine. The drug is synthesized by the use of 5H-dibenz[b,f]azepine and phosgene followed by subsequent reaction with ammonia. Carbamazepine is generally used for the treatment of seizure disorders and neuropathic pain, it …
This chapter includes the aspects of carbamazepine. The drug is synthesized by the use of 5H-dibenz[b,f]azepine and phosgene followed …
[Effects of lithium, valproic acid, carbamazepine and antipsychotic agents on cognition in bipolar disorders-A systematic review].
Leopold S, Quante A. Leopold S, et al. Nervenarzt. 2023 May;94(5):417-424. doi: 10.1007/s00115-023-01454-y. Epub 2023 Mar 15. Nervenarzt. 2023. PMID: 36922444 Free PMC article. Review. German.
BACKGROUND: Until now the long-term consequences of the medical treatment for bipolar disorder have barely been examined, especially the consequences with respect to cognitive impairment and dementia. ...OBJECTIVE: The effects of long-term consequences of lithium, valproic …
BACKGROUND: Until now the long-term consequences of the medical treatment for bipolar disorder have barely been examined, especially …
Clinical use of carbamazepine for bipolar disorders.
Wang PW, Ketter TA. Wang PW, et al. Expert Opin Pharmacother. 2005 Dec;6(16):2887-902. doi: 10.1517/14656566.6.16.2887. Expert Opin Pharmacother. 2005. PMID: 16318439 Review.
Two recently completed large, randomised, double-blind, placebo-controlled trials supporting the efficacy of carbamazepine (CBZ) extended-release capsules (ERC) for the treatment of acute manic and mixed episodes have resulted in US FDA approval of CBZ-ERC, and have reinvi …
Two recently completed large, randomised, double-blind, placebo-controlled trials supporting the efficacy of carbamazepine (CBZ) exte …
Historical review of carbamazepine for the treatment of bipolar disorder.
Stoner SC, Nelson LA, Lea JW, Marken PA, Sommi RW, Dahmen MM. Stoner SC, et al. Pharmacotherapy. 2007 Jan;27(1):68-88. doi: 10.1592/phco.27.1.68. Pharmacotherapy. 2007. PMID: 17192163 Review.
Although the parent compound has been available for decades, its approval for bipolar disorder is recent despite numerous clinical trials that have supported its use in both the acute and maintenance phases of bipolar disorder. ...We review the current body of liter …
Although the parent compound has been available for decades, its approval for bipolar disorder is recent despite numerous clinical tr …
Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
Nasrallah HA, Ketter TA, Kalali AH. Nasrallah HA, et al. J Affect Disord. 2006 Oct;95(1-3):69-78. doi: 10.1016/j.jad.2006.04.030. Epub 2006 Jun 15. J Affect Disord. 2006. PMID: 16780960 Review.
There are an increasing number of pharmacologic therapies for bipolar disorder. Two of these agents, the anticonvulsants carbamazepine (CBZ) and valproate (VPA), were first developed over 30 years ago for the treatment of epilepsy, and subsequent studies demonstrate …
There are an increasing number of pharmacologic therapies for bipolar disorder. Two of these agents, the anticonvulsants carbamaze
Practical considerations for carbamazepine use in bipolar disorder.
Fuller MA, Dostrow V, Gupta S, Gazda TD. Fuller MA, et al. Expert Opin Drug Saf. 2006 Jul;5(4):501-9. doi: 10.1517/14740338.5.4.501. Expert Opin Drug Saf. 2006. PMID: 16774489 Review.
Carbamazepine (CBZ) has a long history of successful use in epilepsy and, therefore, has a safety profile that is well characterised. Additionally, an extended-release formulation of CBZ (CBZ-ERC; Equetro, Shire US) has recently been approved for use in bipolar diso
Carbamazepine (CBZ) has a long history of successful use in epilepsy and, therefore, has a safety profile that is well characterised.
Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.
Weisler RH. Weisler RH. Expert Rev Neurother. 2005 Sep;5(5):587-95. doi: 10.1586/14737175.5.5.587. Expert Rev Neurother. 2005. PMID: 16162082 Review.
Carbamazepine has a long history in psychiatry and neurology. More recently, carbamazepine extended-release capsules have been approved by the US Food and Drug Administration for the treatment of manic and mixed episodes associated with bipolar I disorder. ..
Carbamazepine has a long history in psychiatry and neurology. More recently, carbamazepine extended-release capsules have been
A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder.
Hirschfeld RM, Kasper S. Hirschfeld RM, et al. Int J Neuropsychopharmacol. 2004 Dec;7(4):507-22. doi: 10.1017/S1461145704004651. Epub 2004 Sep 30. Int J Neuropsychopharmacol. 2004. PMID: 15458610 Free article. Review.
Bipolar disorder is a recurrent lifelong condition associated with significant morbidity and mortality. ...In addition, a growing body of data for oxcarbazepine suggests that this newer agent may have a similar efficacy profile to carbamazepine, with improved tolera
Bipolar disorder is a recurrent lifelong condition associated with significant morbidity and mortality. ...In addition, a growing bod
Extended-release carbamazepine capsules : in bipolar I disorder.
Swainston Harrison T, Keating GM. Swainston Harrison T, et al. CNS Drugs. 2005;19(8):709-16. doi: 10.2165/00023210-200519080-00006. CNS Drugs. 2005. PMID: 16097852 Review.
An extended-release capsule formulation of carbamazepine is approved for use in adult patients experiencing an acute manic or mixed episode associated with bipolar I disorder. A capsule of extended-release carbamazepine contains three types of bead: immediate …
An extended-release capsule formulation of carbamazepine is approved for use in adult patients experiencing an acute manic or mixed e …
1,501 results